Diabetes Obes Metab. 2024;26(3):1114-1119.
Evaluation of the efficacy of a combination of dapagliflozin and lobeglitazone on glucose concentrations and body fat in patients with type 2 diabetes: Location-F study.
제1저자 최훈지 · 교신저자 임수
소속 (4)
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
- Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Touchstone Diabetes Center, The University of Texas Health Science Center at Houston Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, Houston, Texas, USA.
그 밖의 정보
- 출판 형태
- Letter
- 저널
- Diabetes, obesity & metabolism · eISSN 1463-1326
- 전자 출판
- 2023-12-11
- MeSH
- Humans · Diabetes Mellitus, Type 2* / drug therapy · Hypoglycemic Agents / adverse effects · Benzhydryl Compounds / therapeutic use · Glucose · Adipose Tissue · Blood Glucose · Treatment Outcome · Glucosides* · Pyrimidines* · Thiazolidinediones*
- Substances
- dapagliflozin · lobeglitazone · Hypoglycemic Agents · Benzhydryl Compounds · Glucose · Blood Glucose · Glucosides · Pyrimidines · Thiazolidinediones
- 연구비
- CKD pharmaceutical B-1910-568-001 · Seoul National University Bundang Hospital 14-2015-0014
- 참고문헌
- 13편